Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001193125-26-276236

President & CEO sold 20,000 shares at an average $60.75 ($1,215,056)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROBIN HOWARD W · President & CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-16 Sale : show line 1 in the form 10b5-1 −5,303 $59.97 $318,021 69,742 D
2026-06-16 Sale : show line 2 in the form 10b5-1 −4,697 $60.71 $285,155 65,045 D
2026-06-17 Sale : show line 3 in the form 10b5-1 −5,500 $60.81 $334,455 59,545 D
2026-06-17 Sale : show line 4 in the form 10b5-1 −4,500 $61.65 $277,425 55,045 D
Open-market sales · 20,000 sh · avg $60.75 · $1,215,056
Loading xslF345X06/ownership.xml…